Search Results - David Devos

Refine Results
  1. 1

    Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates by Flore Gouel, Anne-Sophie Rolland, Jean-Christophe Devedjian, Thierry Burnouf, Thierry Burnouf, Thierry Burnouf, David Devos, David Devos

    Published in Frontiers in Neurology (2019-08-01)
    Get full text
    Article


  2. 2

    Trends in Glucocerebrosides Research: A Systematic Review by Mazarine Desplanque, Mazarine Desplanque, Marie-Amandine Bonte, Bernard Gressier, Bernard Gressier, David Devos, David Devos, Marie-Christine Chartier-Harlin, Karim Belarbi, Karim Belarbi

    Published in Frontiers in Physiology (2020-10-01)
    Get full text
    Article


  3. 3

    Early occurrence of inspiratory muscle weakness in Parkinson's disease. by Guillaume Baille, Thierry Perez, David Devos, Valérie Deken, Luc Defebvre, Caroline Moreau

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  4. 4

    Conservative iron chelation for VAC14: Two-year clinical-radiological follow-up by Thomas Ollivier, David Devos, Gregory Kuchcinski, Luc Defebvre, Vincent Huin, Eugenie Mutez

    Published in Journal of Parkinson’s Disease (2025-06-01)
    Get full text
    Article


  5. 5

    Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials by Félix Marchand, Anne-Sophie Blaise, Luc Defebvre, Emeline Cailliau, Stéphanie Bombois, David Devos, Caroline Moreau

    Published in Journal of Parkinson’s Disease (2024-12-01)
    Get full text
    Article


  6. 6

    Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses by Liling Delila, Yu-Wen Wu, Ouada Nebie, Rifa Widyaningrum, Ming-Li Chou, David Devos, Thierry Burnouf

    Published in Platelets (2021-02-01)
    Get full text
    Article


  7. 7

    Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease by James A. Duce, Bruce X. Wong, Hannah Durham, Jean-Christophe Devedjian, David P. Smith, David Devos

    Published in Molecular Neurodegeneration (2017-06-01)
    Get full text
    Article


  8. 8

    Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro by Ouada Nebie, Lassina Barro, Yu-Wen Wu, Folke Knutson, Luc Buée, David Devos, Chih-Wei Peng, David Blum, Thierry Burnouf

    Published in Platelets (2021-02-01)
    Get full text
    Article


  9. 9

    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease by Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

    Published in npj Parkinson's Disease (2018-05-01)
    Get full text
    Article


  10. 10

    Novel variant c.92T > G (p.Val31Gly) in the PFN1 gene (ALS18) responsible for a specific phenotype in a large Bulgarian amyotrophic lateral sclerosis pedigree by Teodor Angelov, Teodora Chamova, Slavena Atemin, Tihomir Todorov, Slavko Ormandzhiev, Ivan Tourtourikov, Ivan Tourtourikov, Albena Todorova, Albena Todorova, David Devos, Ivailo Tournev, Ivailo Tournev

    Published in Frontiers in Neurology (2023-02-01)
    Get full text
    Article


  11. 11

    A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. by Hélène Blasco, Franck Patin, Amandine Descat, Guillaume Garçon, Philippe Corcia, Patrick Gelé, Timothée Lenglet, Peter Bede, Vincent Meininger, David Devos, Jean François Gossens, Pierre-François Pradat

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  12. 12

    Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease? by Caroline Moreau, David Devos, Guillaume Baille, Arnaud Delval, Céline Tard, Thierry Perez, Nicolas Danel-Buhl, David Seguy, Julien Labreuche, Alain Duhamel, Marie Delliaux, Kathy Dujardin, Luc Defebvre

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  13. 13

    Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models? by Franziska Hopfner, Franziska Hopfner, Markus A. Hobert, Corina Maetzler, Clint Hansen, Minh Hoang Pham, Caroline Moreau, Daniela Berg, David Devos, Walter Maetzler, The Fair-Park II study group

    Published in Frontiers in Neurology (2019-08-01)
    Get full text
    Article


  14. 14

    Overview on wearable sensors for the management of Parkinson’s disease by Caroline Moreau, Tiphaine Rouaud, David Grabli, Isabelle Benatru, Philippe Remy, Ana-Raquel Marques, Sophie Drapier, Louise-Laure Mariani, Emmanuel Roze, David Devos, Gwendoline Dupont, Matthieu Bereau, Margherita Fabbri

    Published in npj Parkinson's Disease (2023-11-01)
    Get full text
    Article


  15. 15

    Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials by Simon Witzel, Felix Frauhammer, Petra Steinacker, David Devos, Pierre-François Pradat, Vincent Meininger, Steffen Halbgebauer, Patrick Oeckl, Joachim Schuster, Simon Anders, Johannes Dorst, Markus Otto, Albert C. Ludolph

    Published in Translational Neurodegeneration (2021-08-01)
    Get full text
    Article


  16. 16

    Neuroprotective activity of a virus‐safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models by Liling Delila, Ouada Nebie, Nhi Thao Ngoc Le, Lassina Barro, Ming‐Li Chou, Yu‐Wen Wu, Naoto Watanabe, Masayasu Takahara, Luc Buée, David Blum, David Devos, Thierry Burnouf

    Published in Bioengineering & Translational Medicine (2023-01-01)
    Get full text
    Article


  17. 17

    Preanalytical Issues and Cycle Threshold Values in SARS-CoV‑2 Real-Time RT-PCR Testing: Should Test Results Include These? by Ilka Engelmann, Enagnon Kazali Alidjinou, Judith Ogiez, Quentin Pagneux, Sana Miloudi, Ilyes Benhalima, Mahdi Ouafi, Famara Sane, Didier Hober, Alain Roussel, Christian Cambillau, David Devos, Rabah Boukherroub, Sabine Szunerits

    Published in ACS Omega (2021-03-01)
    Get full text
    Article


  18. 18

    Correction: H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis. by Hélène Blasco, Philippe Corcia, Caroline Moreau, Ségolène Veau, Clémentine Fournier, Patrick Vourc'h, Patrick Emond, Paul Gordon, Pierre-François Pradat, Julien Praline, David Devos, Lydie Nadal-Desbarats, Christian R. Andres

    Published in PLoS ONE (2010-01-01)
    Get full text
    Article


  19. 19

    Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models by Liling Delila, Ouada Nebie, Nhi Thao Ngoc Le, Kelly Timmerman, Deng-Yao Lee, Yu-Wen Wu, Ming-Li Chou, Luc Buée, Szu-Yi Chou, David Blum, David Devos, Thierry Burnouf

    Published in Journal of Biomedical Science (2024-09-01)
    Get full text
    Article


  20. 20

    Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages? by Lucie Hopes, Guillaume Grolez, Caroline Moreau, Renaud Lopes, Gilles Ryckewaert, Nicolas Carrière, Florent Auger, Charlotte Laloux, Maud Petrault, Jean-Christophe Devedjian, Regis Bordet, Luc Defebvre, Patrice Jissendi, Christine Delmaire, David Devos

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


Search Tools: